Financials

  • Market Capitalization 4.34 B
  • Employee 92
  • Founded 2019
  • CEO N/A
  • Website www.dianthustx.com
  • Headquarter Delaware, United States
  • FIGI BBG00FB2NPZ0
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-9.81
Fiyat/satışlar oranı
781.65

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1321
CRSP
CRISPR Therapeutics AG - Common Shares
50.10 USD-2.81%-5.47%-4.70%-28.48%4.84 B USD
1357
DFTX
Definium Therapeutics, Inc. - Common Shares
34.38 USD-2.33%-2.72%-14.50%+127.53%4.62 B USD
1455
ADPT
Adaptive Biotechnologies Corporation - Common Stock
25.28 USD-1.13%-4.06%+1.94%+46.47%4.03 B USD
1473
EWTX
Edgewise Therapeutics, Inc. - Common Stock
36.28 USD-5.64%-8.52%-18.82%+138.21%3.94 B USD

Haberler